Xing Luo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xing Luo

Showing results (391-400 of 393) with videos related to

Pageof 40

Sort By:

You have reached the last page of results.This site can display upto 393 results.

Journal of the National Cancer Institute|January 30, 2022

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung CancerXiao-Shan Wang, Yi-Feng Bai, Vivek Verma, et al.

BMC Psychiatry|June 12, 2024

Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studyXing Luo, Fang Liu, Jin Lu, et al.

Signal Transduction and Targeted Therapy|April 13, 2025

Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.

Pageof 40

Search research articles

Showing results (391-400 of 393) with videos related to

Sort By:

Pageof 40

You have reached the last page of results.This site can display upto 393 results.

Journal of the National Cancer Institute|January 30, 2022

BMC Psychiatry|June 12, 2024

Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort studyXing Luo, Fang Liu, Jin Lu, et al.

Signal Transduction and Targeted Therapy|April 13, 2025

Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trialHuijie Bian, Liang Chen, Zheng Zhang, et al.

Pageof 40